Company Snapshot

Investment Thesis

Boston Scientific delivers innovative devices for cardiovascular, structural heart, endoscopy, and urology procedures with high-growth franchises.

  • Structural Heart: WATCHMAN and Farapulse pipelines fuel double-digit expansion.
  • Neuromodulation: Deep brain and pain therapies expand addressable patients.
  • Global Scale: Emerging market adoption adds incremental growth.

Strategic Mix

Cardiology Interventional, electrophysiology, structural heart
MedSurg Endoscopy, urology, pelvic health
Neuromodulation Pain, DBS, peripheral nerve stimulation
Emerging Technologies Digital health, robotics, AI planning

Narrative mix based on public filings, investor days, and Maxim research.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is onboarding this coverage set now. Live market stats and proprietary dashboards will populate after the first nightly data refresh.

Strategic Insights

Clinical Evidence

Strong trial data underpin reimbursement expansion.

Portfolio Balance

Mix of high-growth and cash-generating segments.

Pipeline

Acquisitions bring novel energy-based ablation platforms.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...